SynthesisJournal of neurology2026

Efficacy and safety of complement inhibitors and FcRn blockers in generalized AChR antibody-positive myasthenia gravis: a meta-analysis.

Eugenia Filippakopoulou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.